Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

NanoVation Therapeutics: Vancouver, British Columbia, CA

2021-07-05 to 2023-06-30
Employment
Source: Self-asserted source
Kevin An

Education and qualifications (2)

University of British Columbia: Vancouver, CA

2023-08-21 to present | Doctor of Medicine
Education
Source: Self-asserted source
Kevin An

University of British Columbia: Vancouver, British Columbia, CA

2016-09 to 2021-04 | Bachelor of Science in Pharmacology
Education
Source: Self-asserted source
Kevin An

Works (7)

Language inclusivity in health research: An institutional current state quality assessment

Ethics, Medicine and Public Health
2023-12 | Journal article
DOI: 10.1016/j.jemep.2023.100946
Part of ISSN: 2352-5525
Contributors: K. An; J. Claydon; Melissa Woodward; Jiawen; S. Chhina; B. Udall; Quynh Doan
Source: Self-asserted source
Kevin An

Maintenance of hematopoietic stem cell niche homeostasis requires gap junction–mediated calcium signaling

Proceedings of the National Academy of Sciences
2023-11-07 | Journal article
DOI: 10.1073/pnas.2303018120
Contributors: Kevin Y. L. Ho; Kevin An; Rosalyn L. Carr; Alexandra D. Dvoskin; Annie Y. J. Ou; Wayne Vogl; Guy Tanentzapf
Source: check_circle
Crossref

Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe In Situ Gene Editing in Human Skin.

ACS Nano
2023-11-02 | Journal article
DOI: 10.1021/acsnano.3c08644
PMID: 37918441
Contributors: Bolsoni J; Liu D; Mohabatpour F; Ebner R; Sadhnani G; Tafech B; Leung J; Shanta S; An K; Morin T et al.
Source: Self-asserted source
Kevin An

83 Long-Circulating Lipid Nanoparticles for Agnostic Nucleic Acid Delivery to the Bone Marrow and Beyond

Molecular Therapy
2023-05-01 | Journal article
Contributors: Kevin An; Daniel Kurek; Pieter R. Cullis; Dominik Witzigmann; Jayesh A. Kulkarni
Source: Self-asserted source
Kevin An

On the Influence of Nucleic Acid Backbone Modifications on Lipid Nanoparticle Morphology

Langmuir
2022-11-22 | Journal article
DOI: 10.1021/acs.langmuir.2c01492
Contributors: Kevin An; Daniel Kurek; Mark Mahadeo; Yao Zhang; Jenifer L. Thewalt; Pieter R. Cullis; Jayesh A. Kulkarni
Source: check_circle
Crossref

EP16.03-039 Characterizing SHPRH as a Novel Tumor Suppressor Gene in Lung Adenocarcinoma

Journal of Thoracic Oncology
2022-09 | Journal article
DOI: 10.1016/j.jtho.2022.07.1100
Part of ISSN: 1556-0864
Contributors: T.S. Sihota; Y.T. Chen; A.L. Nagelberg; J.L.M. Chow; R. Shi; K. An; W.W. Lockwood
Source: Self-asserted source
Kevin An

Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways

European Journal of Pharmaceutical Sciences
2022-06 | Journal article
DOI: 10.1016/j.ejps.2022.106234
Part of ISSN: 0928-0987
Source: Self-asserted source
Kevin An
grade
Preferred source (of 2)‎

Peer review (4 reviews for 2 publications/grants)

Review activity for Advanced healthcare materials (1)
Review activity for Advanced materials. (3)
How many people are using ORCID?